Scilex Holding Co Logo

Scilex Holding Co

Develops and commercializes non-opioid products for acute and chronic pain management.

SCLX | US

Overview

Corporate Details

ISIN(s):
US80880W2052 (+3 more)
LEI:
Country:
United States of America
Address:
960 SAN ANTONIO ROAD, 94303 PALO ALTO
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Scilex Holding Company is an innovative pharmaceutical company focused on acquiring, developing, and commercializing non-opioid products for the management of acute and chronic pain. The company's portfolio is designed to provide effective alternatives to traditional opioid medications, aiming to improve patient quality of life. Scilex utilizes proprietary technologies, including advanced adhesion and drug delivery systems like transdermal patches, precision-dosing anti-inflammatory oral solutions, and liquid ready-to-use analgesics for conditions such as migraines.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Scilex Holding Co filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Scilex Holding Co

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Scilex Holding Co via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Connect Biopharma Holdings Ltd Logo
Develops immune modulators for T cell-driven inflammatory diseases like asthma and COPD.
United States of America CNTB
Context Therapeutics Inc. Logo
Clinical-stage biopharma developing T cell engaging bispecific antibodies for solid tumors.
United States of America CNTX
Contineum Therapeutics, Inc. Logo
Develops oral small molecule therapies for neurological, inflammatory, and fibrotic diseases.
United States of America CTNM
CORCEPT THERAPEUTICS INC Logo
Develops and commercializes cortisol-modulating drugs for severe disorders like Cushing's syndrome.
United States of America CORT
CORESTEMCHEMON Inc. Logo
Develops stem cell therapies & provides preclinical CRO services to pharma & biotech.
South Korea 166480
Corline Biomedical AB Logo
Develops heparin-based coatings for medical device biocompatibility and regenerative medicine.
Sweden CLBIO
CorMedix Inc. Logo
Develops a catheter lock solution to prevent bloodstream infections in hemodialysis patients.
United States of America CRMD
Cosma Spolka Akcyjna Logo
Produces natural hemp supplements and pharmaceutical raw materials for retail & wholesale markets.
Poland COS
COSMO Pharmaceuticals N.V. Logo
Specialty pharma for gastroenterology/dermatology, offering colon treatments & manufacturing services.
Netherlands COPN
Cosmos Health Inc. Logo
A global healthcare firm developing & distributing nutraceuticals, generics, and OTC medications.
United States of America COSM

Talk to a Data Expert

Have a question? We'll get back to you promptly.